Does vitamin C help prevent or treat the common cold?

June 27, 2005

Linus Pauling's book Vitamin C and The Common Cold, published in 1970, was a bestseller and led many people to believe in the value of the vitamin for cold prevention and treatment. But an article in this month's PLoS Medicine reviewing all of the best clinical research on this topic, suggests that the public's enthusiasm for the vitamin may be unjustified.

Robert M Douglas of the Australian National University, Canberra, and Harri Hemilä of the University of Helsinki, Finland, reviewed the best quality studies on vitamin C and the common cold done over the last 65 years. All of these studies compared a daily dose of 200mg of vitamin C or more against a dummy pill (placebo).

Did vitamin C given for prevention reduce the risk of picking up a cold? The authors looked at 23 studies done in the general population, using doses of up to 2g daily, and found that vitamin C did not reduce the risk. They conclude that "the lack of effect of prophylactic vitamin C supplementation on the incidence of common cold in normal populations throws doubt on the utility of this wide practice."

In these prevention studies, those people who were given vitamin C and then caught a cold experienced a small reduction in the duration of the cold compared with those taking a placebo. The authors say that the clinical significance of this minor reduction "is questionable, although the consistency of these findings points to a genuine biological effect."

But the authors did find evidence that the vitamin could help prevent colds in people exposed to extreme physical exertion or cold weather. They found six studies in which the vitamin or a placebo was given to marathon runners, skiers and soldiers exposed to significant cold and/or physical stress. Those taking the vitamin experienced, on average, a 50% reduction in common cold incidence. The authors urge "great caution", though, in making generalizations from this finding in 6 studies that is mainly based on marathon runners.

What about vitamin C as a possible treatment for an established cold? The authors found seven trials (all in adults) evaluating whether vitamin C taken when their symptoms started would shorten the cold. When they looked at all seven studies together, they found no benefit from taking the vitamin. But in one of the seven trials, patients took a single very high dose of the vitamin (8 g) on the day their symptoms started and experienced a shorter illness compared with people who took a placebo pill. (3) The authors say that the results in this single trial are "tantalising and deserve further assessment."

Douglas and Hemilä's article summarizes their more detailed review of the evidence that is published by the Cochrane Library (see www.cochrane.org) and that is freely available via the PLoS Medicine website.
-end-
Citation: Douglas RM, Hemilia H (2005) Vitamin C for preventing and treating the common cold. PLoS Med 2(6): e168.

CONTACT:
Robert M Douglas
Australian National University
National Centre for Epidemiology and Population Health
ACT 0200
Canberra, Australia
+61-2-6125-9940
+61-2-6125-0740 (fax)
bobdouglas@netspeed.com.au

PLEASE MENTION PLoS Medicine (www.plosmedicine.org) AS THE SOURCE FOR THESE ARTICLES. THANK YOU.

All works published in PLoS Medicine are open access. Everything is immediately available without cost to anyone, anywhere--to read, download, redistribute, include in databases, and otherwise use--subject only to the condition that the original authorship is properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.

PLOS

Related Placebo Articles from Brightsurf:

Effect of fluvoxamine vs placebo on clinical deterioration in outpatients with symptomatic COVID-19
This randomized trial compares the effects of fluvoxamine, a selective serotonin reuptake inhibitor with immunomodulatory effects, versus placebo on a composite of dyspnea or pneumonia and oxygen desaturation among adult outpatients with polymerase chain reaction-confirmed mild COVID-19 illness.

Hydroxychloroquine no more effective than placebo in preventing COVID-19
Clinical trial with COVID-19 testing of participants shows health care workers in contact with coronavirus patients who took hydroxychloroquine each day did not reduce their rate of infection.

Compared to placebo, vitamin D has no benefit for severe asthma attacks
Contrary to earlier observational results, vitamin D supplements do not prevent severe asthma attacks in at-risk children, according to the first placebo-controlled clinical trial to test this relationship.

UMN trial shows hydroxychloroquine has no benefit over placebo in preventing COVID-19
Today, University of Minnesota Medical School researchers published the results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19.

The placebo effect and psychedelic drugs: tripping on nothing?
A new study from McGill suggests that, in the right context, some people may experience psychedelic-like effects from placebos alone.

Methotrexate reduces joint damage progression over placebo in erosive hand OA
According to new research findings presented at the 2019 ACR/ARP Annual Meeting, methotrexate did not demonstrate superior efficacy over placebo for pain relief and function evolution at three and 12 months in patients with erosive hand osteoarthritis, but did significantly reduce the progression of joint damage over placebo and seems to facilitate bone remodeling in these patients.

Botulinum toxin reduces chronic migraine attacks, compared to placebo
A growing body of evidence supports the effectiveness of botulinum toxin injections in reducing the frequency of chronic migraine headaches, concludes an updated review and analysis in the January issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

Opioids vs. placebo, nonopioid alternatives for chronic noncancer pain
An estimated 50 million adults in the United States were living with chronic noncancer pain in 2016 and many of them were prescribed opioid medications, even though a clinical benefit is uncertain.

Probiotic no better than placebo for acute gastroenteritis in children
While probiotics are often used to treat acute gastroenteritis (also known as infectious diarrhea) in children, the latest evidence shows no significant differences in outcomes, compared to a placebo.

Most common shoulder operation is no more beneficial than placebo surgery
In a landmark study published this week in the BMJ, Finnish researchers show that one of the most common surgical procedures in the Western world is probably unnecessary.

Read More: Placebo News and Placebo Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.